(Boston, MA, January 5, 2011) – The life sciences practice at Foley Hoag LLP opens 2011 with the arrival of noted life sciences lawyer Hemmie Chang, who joins the firm this week from Ropes & Gray.
Ms. Chang represents both large pharmaceutical companies and emerging companies in connection with mergers and acquisitions, licensing transactions and financing matters. She also advises investors in life sciences companies. Ms. Chang joins a strong life sciences group at Foley Hoag including lawyers from the firm’s intellectual property, corporate, government strategies and litigation areas.
“Foley Hoag has long been a leader in the life sciences industry and is committed to serving both its established and emerging clients effectively and efficiently,” said Ms. Chang. “Lawyers at Foley Hoag have deep roots in the industry, strong connections to leading organizations, and ties to important sources of funding, centers of research and innovation, and government. The firm’s nimble approach to serving its clients attracted me and I am excited to have this opportunity to help expand Foley Hoag’s life sciences practice.”
“Our life sciences practice has enjoyed tremendous growth and success in 2010 on many fronts, including additions to our corporate and government strategies areas. We are eager to build on that momentum and look forward to Hemmie’s arrival to start the new year,” said Jeffrey L. Quillen, Co-Chair of Foley Hoag’s Life Sciences Practice and a transactional lawyer. “With transaction activity in the life sciences industry increasing, Hemmie will be a terrific complement to our team.”
Ms. Chang is a frequent speaker on topics in the life sciences industry, presenting at BIO 2010 on the topic of “How to Acquire New Products and Technologies: What’s New/What’s Not”. She also serves in an advisory capacity to several diversity-related service providers and initiatives, including the South Cove Nursing Home, Franklin Square House Foundation and the Asian Task Force Against Domestic Violence. After her arrival at Foley Hoag, Ms. Chang, who was the first Asian American partner at her previous firm, will continue her work on diversity-related efforts by supporting Foley Hoag’s longstanding relationship with The Boston Lawyers Group.
Ms. Chang is a graduate of Harvard Law School where she was an editor of the Harvard Law Review and received her undergraduate degree from Princeton University’s Woodrow Wilson School of Public & International Affairs.
Lawyers in Foley Hoag’s life sciences practice provide a full range of services including patent litigation, prosecution and strategy; corporate finance and securities; mergers, acquisitions and strategic alliances; FDA and reimbursement; government strategies; venture capital and emerging companies; and product liability and complex tort. Many lawyers and specialists in the practice were previously employed as scientists, engineers, physicians, government officials and political advisors. With these backgrounds and experiences, Foley Hoag brings diversity and depth of knowledge to its clients, which include manufacturers of medical devices, biotech or pharmaceutical products, leading research institutions and major industry advocacy organizations.
About Foley Hoag
Foley Hoag is a 225-attorney firm with offices in Boston, Waltham and Washington DC. Through these offices, we represent clients in diverse industries such as technology, energy, life sciences, healthcare and professional services gain a competitive advantage by providing strategic legal advice tailored for their business goals at every stage of their growth. Our office in Washington, DC also serves as our bridge to the international marketplace, with highly respected practices in both international arbitration and litigation and corporate social responsibility. Our practice mix reflects a powerful blend of regional, national and international expertise. We are focused on what we do best - helping our clients succeed with their business goals. For more information, visit www.foleyhoag.com
